Detection of apolipoproteins B-48 and B-100 carrying particles in lipoprotein fractions extracted from human aortic atherosclerotic plaques in sudden cardiac death cases

Clinica Chimica Acta

Volumn 390, Issue 1-2, 2008, Pages 38-43

  Nakano, Takamitsu ^a   Nakajima, Katsuyuki ^a,b   Niimi, Manabu ^a   Fujita, Masaki Q ^b   Nakajima, Yasuhiro ^b   Takeichi, Sanae ^c   Kinoshita, Makoto ^d   Matsushima, Teruhiko ^e   Teramoto, Tamio ^d   Tanaka, Akira ^f  

^a JAPAN IMMUNORESEARCH LABORATORIES   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e Tsukuba Memorial Hospital   (Japan)

^f KAGAWA NUTRITION UNIVERSITY   (Japan)

Author keywords

ApoB 100; Atherosclerotic plaques; Chylomicrons; VLDL, ApoB 48

Indexed keywords

APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; CHOLESTEROL; CHYLOMICRON; LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

AORTA ATHEROSCLEROSIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DENATURATION; PROTON NUCLEAR MAGNETIC RESONANCE; SMALL INTESTINE; SUDDEN DEATH; TRIACYLGLYCEROL BLOOD LEVEL;

AORTA; APOLIPOPROTEIN B-100; APOLIPOPROTEIN B-48; ATHEROSCLEROSIS; BLOTTING, WESTERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEATH, SUDDEN, CARDIAC; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS;

EID: 39649120533     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.12.012     Document Type: Article

References (26)

1. Kane J.P., Hardman D.A., and Paulus H.E. Heterogeneity of apolipoprotein B isolation of new species from human chylomicrons. Proc Natl Acad Sci USA 71 (1980) 2465-2469
2. Hardman D.A., and Kane J.P. Isolation and characterization of apolipoprotein B-48. Meth Enzymol 128 (1986) 262-272
3. Campos H., Khoo C., and Sacks F.M. Diurnal and acute patterns of postprandial apolipoprotein B-48 in VLDL, IDL, and LDL from normolipidemic humans. Atherosclerosis 181 (2005) 345-351
4. Ginsberg H.N. New perspectives on atherogenesis: role of abnormal triglyceride-rich lipoprotein metabolism. Circulation 43 (2002) 1026-1034
5. Yla-Herttuala S., Jaakkola O., Ehnholm C., et al. Characterization of two lipoproteins containing apolipoproteins B and E from lesion-free human aortic intima. J Lipid Res 29 (1988) 563-572
6. Rapp J.H., Lespine A., Hamilton R.L., et al. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler Thromb 14 (1994) 1767-1774
7. Kinoshita M., Kojima M., Matsushima T., and Teramoto T. Determination of apolipoprotein B-48 in serum by a sandwich ELISA. Clin Chim Acta 351 (2005) 115-120
8. Usui S., Hara Y., Hosaki S., and Okazaki M. A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC. J Lipid Res 43 (2002) 805-814
9. Takeichi S., Nakajima Y., Osawa M., et al. The possible role of remnant-like particles as risk factor for sudden cardiac death. Int J Leg Med 110 (1997) 213-219
10. Takeichi S., Yukawa N., Nakajima Y., et al. Association of plasma triglyceride-rich lipoprotein remnants with coronary atherosclerosis in cases of sudden cardiac death. Atherosclerosis 42 (1999) 309-315
11. Sakai N., Uchida Y., Ohashi K., et al. Measurement of fasting serum.apoB-48 levels in normolipidemic and hyperlipidemic subjects by ELISA. J Lipid Res 44 (2003) 1256-1262
12. Zilversmit D.B. Atherogenesis: a postprandial phenomenon. Circulation 60 3 (1979) 473-485
13. Powell L.M., Wallis S.C., Pease R.J., Edwards Y.H., Knott T.J., and Scott J. A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine. Cell 11 50 (1987) 831-840
14. Peel A., Zampelas A., Williams C., and Gould B. A novel antiserum specific to apolipoprotein B-48 application in the investigation of postprandial lipidaemia in humans. Clin Sci 85 (1993) 521-524
15. Guo Q., Avramoglu R.K., and Adeli K. Intestinal assembly and secretion of highly dense/lipid-poor apolipoprotein B48-containing lipoprotein particles in the fasting state: evidence for induction by insulin resistance and exogenous fatty acids. Metabolism 54 (2005) 689-697
16. Phillips M.L., Pullinger C., Kroes I., et al. A single copy of apolipoprotein B-48 is present on the human chylomicron remnant. J Lipid Res 38 (1997) 1170-1177
17. Mackness M.I., and Durrington P.N. Lipoprotein separation and analysis for clinical studies. In: Converse C.A., and Skinner E.R. (Eds). Lipoprotein analysis. A practical approach (1992), Oxford University Press 1-42
18. Seishima M., Noma A., Torizawa H., and Muto Y. Changes of serum apolipoprotein levels after oral administration of fat in human subjects. Atherosclerosis 73 (1988) 39-43
19. Bergeron N., and Havel R.J. Influence of diets rich in saturated and omega-6 polyunsaturated fatty acids on the postprandial responses of apolipoprotein B-48, B-100, E and lipids in triglyceride-rich lipoproteins. Arterioscler Thromb Vasc Biol 15 (1995) 2111-2121
20. Lovegrove J.A., Isherwood S.G., Jackson K.G., Williams C.M., and Gould B.J. Quantification of apolipoprotein B-48 in triglyceride-rich lipoproteins specific enzyme-linked immunosorbent assay. Biochim Biophys Acta 1301 (1996) 221-229
21. Uchida Y., Kurano Y., and Ito S. Establishment of monoclonal antibody against human apo B-48 and measurement of apo B-48 in serum by ELISA method. J Clin Lab Anal 12 (1998) 289-292
22. Zampelas A., Roche H., Knapper J.M.E., et al. Differences in postprandial lipaemic response between Northern and Southern Europeans. Atherosclerosis 139 (1998) 83-93
23. Nakajima K, Nakajima Y, Takeichi S, Fujita MQ. ApoB-100 carrying lipoprotein, but not apoB-48, is the major subset of proatherogenic remnant-like lipoprotein particles detected in plasma of sudden cardiac death cases. Atherosclerosis in press.
24. Pal S., Semorine K., Watts G.F., and Mamo J. Identification of lipoproteins of intestinal origine in human atherosclerotic plaque. Clin Chem Lab Med 41 (2003) 792-795
25. Brown M.L., Rampraqsad M.P., Umeda P.K., et al. A macrophage receptor for apolipoprotein B-48: cloning, expression, and atherosclerosis. Proc Natl Acad Sci USA 97 (2000) 7488-7493
26. Nakajima K., Nakano T., and Tanaka A. The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma. Clin Chim Acta 367 (2006) 36-47